We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Sunday
May 08
16:55 - 17:55
Room D3
Oligometastatic disease
Joachim Widder, Austria;
Jonas Willmann, Switzerland
Proffered Papers are presented at one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be streamed.
Proffered Papers
Clinical
16:55 - 17:05
Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis
Matthias Guckenberger, Switzerland
OC-0599
17:05 - 17:15
SBRT for oligo-metastatic disease in Belgium: a prospective national registration project.
Yolande Lievens, Belgium
OC-0600
17:15 - 17:25
Incidence and outcomes of oligometastatic esophagogastric cancer: A multicenter cohort study
Tiuri Kroese, Switzerland
OC-0601
17:25 - 17:35
A pREDictive model of polymetastatic disease on oligometastatic colorectal cancer: the RED LaIT-SABR
Luca Nicosia, Italy
OC-0602
17:35 - 17:45
PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity
Thomas Zilli, Switzerland
OC-0603
17:45 - 17:55
Early toxicity after SABR of oligometastatic bony metastases in the BONY M phase II trial
Nicklas Juel Spindler, Denmark
OC-0604